ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 844

Identification of Subclinical Skin Involvement By High Frequency Ultrasound in Systemic Sclerosis Patients

Barbara Ruaro, Alberto Sulli, Elena Bernero, Marco A. Cimmino, Sabrina Paolino and Maurizio Cutolo, Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genoa, Italy

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: skin, systemic sclerosis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Skin involvement may be evaluated in systemic sclerosis (SSc) by modified Rodnan skin score (mRSS), the validated method to distinguish between patients with limited (lcSSc) or diffuse (dcSSc) cutaneous skin involvement (1). In lcSSc the skin involvement is confined to the extremities (hands, forearms, feet, legs and face), whilst it is present also on arms, chest, abdomen and thighs in dcSSc patients (2). However, mRSS is unable to identify slight alterations in dermal thickness (DT) (3), and several studies report the utility of high frequency skin ultrasound (US) for early identification of skin involvement in SSc patients (4,5). DT was found progressively higher in SSc patients with worsening pattern of nailfold microangiopathy (5).

The aim of this study was to measure DT by US in both SSc patients and healthy subjects, looking for differences between the groups and correlations between US and mRSS.

Methods: Forty-eight SSc patients (ACR/EULAR criteria) (mean age 64±11SD years, mean disease duration 6±5 years) and 20 healthy subjects (mean age 66±14 years) were enrolled, after informed consent (1). Dermal thickness (DT) was evaluated by both mRSS and US transducer with 22 MHz frequency (Esaote, Genoa, Italy) at the level of the usual seventeen skin areas (cheeks, fingers, dorsum of hands, forearms, arms, chest, abdomen, thighs, legs, feet) in both SSc patients and healthy subjects. Nailfold videocapillaroscopy (NVC) was also performed to detect and classify SSc patients into the proper pattern of nailfold microangiopathy (“early”, “active” or “late”) (6).

Results: By US, DT was found significantly higher in both dcSSc and lcSSc patients than in healthy subjects in all the seventeen skin areas (median total DT 21.5 vs 19.1 vs 14.9 millimetres, respectively; p<0.01). Of great importance, lcSSc patients showed a statistically significant higher DT than healthy subjects in all the skin areas even with normal mRSS (mRSS=0), in contrast with the classificative diagnosis of lcSSc (median DT 1.20 vs 0.86 for right arm, 1.10 vs 0.86 for left arm, 1.30 vs 1.13 for chest, 1.40 vs 1.13 for abdomen, 1.40 vs 1.10 for right thigh, 1.40 vs 1.10 for left  thigh, respectively; p<0.01). A significant progressive increase of DT was observed by US in SSc patients with different NVC pattern of microangiopathy at the level of all areas  (median total DT 17.53 vs 21.20 vs 21.43 millimetres respectively for “early”, “active”, or “late” pattern, p<0.05). Finally, a statistically significant positive correlation was found between mRss and US in DT evaluation (r=0.67, p<0.0001).

Conclusion: This study demonstrates the utility of high frequency skin US to detect the subclinical diffuse dermal involvement even where the mRSS is normal in patients with lcSSc. This observation could make a contribution for future classification of the disease.

References: 1. Clements PJ, et al. Arthritis & Rheumatism 2000; 43: 2445–54. 2. LeRoy EC, et al. J Rheumatol 2001;28:1573–6.   3. Hachulla E, et al. Clinic Rev Allerg Immunol 2011; 40: 78-83.  4. Moore TL, et al. Rheumatology 2003; 42: 1559-63.   5. Sulli A, et al. Ann Rheum Dis. 2014; 73: 247-51.  6. Cutolo M, et al. Nature Rev Rheumatol. 2010;6:578-87.


Disclosure: B. Ruaro, None; A. Sulli, None; E. Bernero, None; M. A. Cimmino, None; S. Paolino, None; M. Cutolo, None.

To cite this abstract in AMA style:

Ruaro B, Sulli A, Bernero E, Cimmino MA, Paolino S, Cutolo M. Identification of Subclinical Skin Involvement By High Frequency Ultrasound in Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/identification-of-subclinical-skin-involvement-by-high-frequency-ultrasound-in-systemic-sclerosis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-subclinical-skin-involvement-by-high-frequency-ultrasound-in-systemic-sclerosis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology